Sunitinib in metastatic renal cell carcinoma (mRCC): Preliminary assessment of toxicity in an expanded access trial with subpopulation analysis

被引：0
|
作者：
Gore, M. E.
Porta, C.
Oudard, S.
Bjarnason, G.
Castellano, D.
Szczylik, C.
Mainwaring, P. N.
Schoffski, P.
Rini, B. I.
Bukowski, R. M.
机构：
[1] Royal Marsden Hosp NHS Trust, London, England
[2] IRCCS San Matteo Univ Hosp Fdn, Pavia, Italy
[3] Hop Europeen Georges Pompidou, Paris, France
[4] Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada
[5] Hosp Univ 12 Octubre, Madrid, Spain
[6] Mil Inst Med, Warsaw, Poland
[7] Mater Adult Hosp, South Brisbane, Australia
[8] Leuven Canc Inst, Leuven, Belgium
[9] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5010
引用
收藏
页数：1
相关论文
共 50 条
  • [41] EXPANDED-ACCESS PROGRAM (EAP) OF SUNITINIB IN 458 PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Sternberg, C. N.
    Porta, C.
    Bracarda, S.
    Carteni, G.
    Lo Re, G.
    Ruggeri, E. M.
    Conte, P.
    Monfardini, S.
    Gasparini, G.
    Ciuffreda, L.
    ANNALS OF ONCOLOGY, 2008, 19 : 194 - 194
  • [42] Looking for predictive biomarkers for sunitinib in metastatic renal clear cell carcinoma (mRCC)
    Maroto, P.
    Esteban, E.
    Méndez-Vidal, M. J.
    Fernandez-Parra, E. M.
    Leon, L.
    Perez-Valderrama, B.
    Domenech, M.
    Calderero, V.
    Perez-Gracia, J. L.
    Algaba, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S676 - S676
  • [43] SAFETY PROFILE OF SUNITINIB AND SORAFENIB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)
    Massari, Francesco
    Sperandi, Francesca
    Cricca, Antonia
    Melotti, Barbara
    Martoni, Andrea Angelo
    ANNALS OF ONCOLOGY, 2009, 20
  • [44] CARDIOTOXICITY IN METASTATIC RENAL CELL CARCINOMA (mRCC) PATIENTS TREATED WITH SUNITINIB (SU)
    Ballatore, Valentina
    Prati, Veronica
    Ruatta, Fiorella
    Galizia, Danilo
    Grignani, Giovanni
    Aglietta, Massimo
    Ortega, Cinzia
    ANTICANCER RESEARCH, 2012, 32 (05) : 1876 - 1877
  • [45] Pharmacokinetics (PK) and efficacy of sunitinib in patients with metastatic renal cell carcinoma (mRCC).
    Houk, B. E.
    Amantea, M.
    Motzer, R. J.
    Michaelson, M. D.
    Rini, B. I.
    George, D. J.
    Redman, B. G.
    Hudes, G. R.
    Poland, B.
    Bello, C. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 224S - 224S
  • [46] Hypertension and cardiotoxicity in metastatic renal cell carcinoma (mRCC) treated with sunitinib (SU)
    Prati, Veronica
    Ortega, Cinzia
    Ballatore, Valentina
    Galizia, Danilo
    Ruatta, Fiorella
    Bonzano, Alessandro
    Aliberti, Sandra
    Grignani, Giovanni
    Aglietta, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Sunitinib in patients with cytokine-refiractory metastatic renal cell carcinoma (mRCC)
    George, D. J.
    Michaelson, M. D.
    Rosenberg, J. E.
    Redman, B. G.
    Hudes, G. R.
    Bukowski, R. M.
    Kim, S. T.
    Chen, I.
    Wilding, G.
    Motzer, R. J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 304 - 304
  • [48] Gut microbiome composition and response to sunitinib in metastatic renal cell carcinoma (mRCC).
    Gong, Jun
    Dizman, Nazli
    Poroyko, Valeriy
    Won, Haejung
    Bergerot, Cristiane Decat
    Bergerot, Paulo Gustavo
    Maia, Manuel C.
    Hsu, Joann
    Frankel, Paul Henry
    Jones, Jeremy
    Salgia, Ravi
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [49] Cabozantinib in metastatic renal cell carcinoma (mRCC): Data from UK expanded access program (EAP)
    Lista, A. Gomez de Liano
    Venugopal, B.
    Fife, K.
    Symeonides, S.
    Vasudev, N. S.
    Rudman, S. M.
    Vohra, S.
    Khasati, L.
    Pettinger, C.
    Szabados, B.
    Morrison, L.
    Powles, T.
    Boleti, E.
    ANNALS OF ONCOLOGY, 2018, 29 : 317 - 317
  • [50] Prospective phase II study of sunitinib rechallenge in metastatic renal cell carcinoma (mRCC): A GION trial.
    Porta, Camillo
    Ferrari, Vittorio D.
    Zucali, Paolo Andrea
    Fornarini, Giuseppe
    Bernardo, Antonio
    Falconeri, Andrea
    Ferrari, Alessandra
    Santarossa, Sandra
    Pappagallo, Giovanni L.
    Bearz, Alessandra
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345